Fortimedix

Nuth, Netherlands Founded: 1999 • Age: 27 yrs Acquired By Medtronic
Single-port surgical platform is developed for laparoscopic procedures.

About Fortimedix

Fortimedix is a Healthcare company based in Nuth (Netherlands) founded in 1999, and was acquired by Medtronic in November 2024. Single-port surgical platform is developed for laparoscopic procedures. Fortimedix has raised $12 million across 1 funding round from investors including Medtronic and Brightlands Venture Partners. The company has 1 employees. Fortimedix offers products and services including Articulating Instrument Technology. Its focus areas include Life Sciences, Surgical Instruments, Surgical Access and Closure and Laparoscopic Access Device. Its legal entity is FORTIMEDIX USA INC.

Company details

Fortimedix provides the Symphonx Surgical Platform which is a single-port surgery solution compatible with a standard 15mm trocar. The symphonX Surgical Platform is composed of the symphonX Introducer and Instruments that are used in minimally invasive abdominal laparoscopic surgery. The symphonX Introducer is intended to establish a path of entry for laparoscopic instruments for use during minimally invasive abdominal laparoscopic surgery in combination with the symphonX Instruments. The symphonX Instruments are intended for use in minimally invasive abdominal laparoscopic surgical procedures for grasping, mobilizing, dissecting, retracting, cutting, cauterizing, ligating, and suctionirrigation of tissue and vessels during laparoscopic procedures. The platform is both FDA 510(k) cleared and CE Mark approved. The company plans to commercially launch the product in Europe in 2017.

Key Metrics
  • Total Equity Funding
    $12M (USD)

    in 1 rounds

  • Latest Funding Round
    $12M (USD), Series A

    Oct 2016

  • Investors
    Medtronic

    & 1 more

  • Employee Count
    1
  • Acquired by
    Medtronic

    (Nov 2024)

Products & Services of Fortimedix

Fortimedix offers a comprehensive portfolio of products and services, including Articulating Instrument Technology.

Articulating Instrument Technology
Medical Device

Provides tools for advanced medical interventions using laser-cut design.

Funding Insights of Fortimedix

Fortimedix has successfully raised a total of $12M through 1 strategic funding round. The most recent funding activity was a Series A round of $12 million completed in October 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $12M
  • Total Rounds 1
  • Last Round Series A β€” $12M
  • First Round $12M

    (Oct 2016)

  • Investors Count 1

All 1 funding rounds of Fortimedix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2016$12MSeries A–Brightlands Venture Partners
–
Valuation history

2 investors in total: 2 institutional.

Investors in Fortimedix

Fortimedix has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Medtronic and Brightlands Venture Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Brightlands Venture Partners is focused on venture capital investments.
brightlandsventurepartners.comGeleen, Netherlands
Medical equipment for treating over 30 chronic diseases is developed.
1949medtronic.comMinneapolis, United States
Premium access

Investor details for Fortimedix

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of Fortimedix

3 dated milestones of Fortimedix across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded Fortimedix is founded.
  2. Funding First funding round of $12.0M.
  3. Exit Acquired by Medtronic.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Fortimedix

Premium access

Complete news archive for Fortimedix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Fortimedix

Fortimedix was founded in 1999 and raised its 1st funding round 17 years after it was founded.

Fortimedix is headquartered in Nuth, Netherlands. It is registered at Nuth, Limburg, Netherlands.

Fortimedix is a funded company, having raised a total of $12M across 1 funding round to date. The company's 1st funding round was a Series A of $12M, raised on Oct 2016.

Fortimedix has 1 employees.

Fortimedix provides the Symphonx Surgical Platform which is a single-port surgery solution compatible with a standard 15mm trocar. The symphonX Surgical Platform is composed of the symphonX Introducer and Instruments that are used in minimally invasive abdominal laparoscopic surgery. The symphonX Introducer is intended to establish a path of entry for laparoscopic instruments for use during minimally invasive abdominal laparoscopic surgery in combination with the symphonX Instruments. The symphonX Instruments are intended for use in minimally invasive abdominal laparoscopic surgical procedures for grasping, mobilizing, dissecting, retracting, cutting, cauterizing, ligating, and suctionirrigation of tissue and vessels during laparoscopic procedures. The platform is both FDA 510(k) cleared and CE Mark approved. The company plans to commercially launch the product in Europe in 2017.

Fortimedix offers Articulating Instrument Technology.

Fortimedix has 2 investors. Key investors include Medtronic, and Brightlands Venture Partners.

Fortimedix operates through Fortimedix Usa Inc..

Yes. Fortimedix was acquired by Medtronic in November 2024.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available